Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Aferian (AFRN) by Steve Moore in ShareProphets
- Buy Bloomsbury Publishing (BMY) by Tom Winnifrith in ShareProphets
- Buy Bloomsbury Publishing (BMY) by Steve Moore in ShareProphets
- Buy Johnson Service Group (JSG) by Tom Winnifrith in ShareProphets
- Buy Johnson Service Group (JSG) by Steve Moore in ShareProphets
- Add Safestore Holdings (SAFE) by Zaven Boyrazian in The Motley Fool
- Sell Ondo Insurtech (ONDO) by Steve Moore in ShareProphets
- Buy Admiral Group (ADM) by Berenberg
- Underperform Lancashire Holdings Limited (LRE) by RBC Capital
- Neutral Abrdn (ABDN) by Citi
- Equal Weight ITV (ITV) by Barclays
- Overweight AIB Group (CDI) (AIBG) by JP Morgan
- Neutral Bank of Ireland Group (CDI) (BIRG) by JP Morgan
- Buy AstraZeneca (AZN) by Jefferies
- Overweight ITV (ITV) by JP Morgan
- Outperform Rentokil Initial (RTO) by RBC Capital
- Hold Hunting (HTG) by John Ficenec in The Times - Tempus
- Outperform Taylor Wimpey (TW.) by RBC Capital
- Avoid eEnergy Group (EAAS) by Steve Moore in ShareProphets
- Buy Hunting (HTG) by Canaccord Genuity
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,440 open tips for GSK (GSK)
| Latest Bid : 2,028.00p | Latest Ask : 2,030.00p |
| High Today : 2,041.00p | Low Today : 1,987.50p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 3,837,103 | MKT Cap : £84143.5M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | DZ Bank | Premium Only | 2025-07-31 11:31:00 31/07/2025 | 8.25% |
| Buy | Simon Watkins | Premium Only | 2025-07-24 10:55:00 24/07/2025 | 46.21% |
| Neutral | Goldman Sachs | Premium Only | 2025-07-21 06:27:00 21/07/2025 | – |
| Hold | Berenberg | Premium Only | 2025-07-18 15:16:00 18/07/2025 | 17.59% |
| Buy | Shore Capital | Premium Only | 2025-07-18 15:02:00 18/07/2025 | 47.68% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.51% | 22/01/2026 |
| Latest Bid : 2,028.00p | Latest Ask : 2,030.00p |
| High Today : 2,041.00p | Low Today : 1,987.50p |
| This Years High : 2,268.00p | This Years Low : 1,264.00p |
| Volume : 3,837,103 | MKT Cap : £84143.5M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | DZ Bank | Premium Only | 2025-07-31 11:31:00 31/07/2025 | 8.25% |
| Buy | Simon Watkins | Premium Only | 2025-07-24 10:55:00 24/07/2025 | 46.21% |
| Neutral | Goldman Sachs | Premium Only | 2025-07-21 06:27:00 21/07/2025 | – |
| Hold | Berenberg | Premium Only | 2025-07-18 15:16:00 18/07/2025 | 17.59% |
| Buy | Shore Capital | Premium Only | 2025-07-18 15:02:00 18/07/2025 | 47.68% |